Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Cathepsin B and L inhibitors described by Nippon Chemiphar

Dec. 3, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

RPR claims dual-action TNF/cAMP phosphodiesterase inhibitors

Dec. 3, 1996

Pharmacopeia reports protein farnesyl transferase inhibitors

Dec. 3, 1996

New farnesyl protein transferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

Dec. 3, 1996

Merck reveals new thrombin inhibitor series

Dec. 3, 1996

Antiproliferative agents disclosed by Kitasato Institute

Dec. 2, 1996

Antihyperlipidemic agents from natural source described by Takeda

Dec. 2, 1996

Potent ACAT inhibitor discovered by Kitasato Institute

Dec. 2, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...